Latitude Discovery is purposefully designed to meet the needs of pre-commercial pharmaceutical, biotechnology and medical device companies who are looking to bring new treatments to market. With billions of commercial medical claims, Latitude Discovery users gain self-service access to the precise market intelligence they need when they need it as they advance through the lengthy commercialization process.
Key capabilities of Latitude Discovery include:
- The ability to quickly create new patient cohorts for analysis and reporting using any combination of diagnosis or procedure with additional filters on patients and providers
- Rapid real-time commercial intelligence visualizations on the size of addressable patient and provider populations, clinical volumes, demographics and payor mix
- Customizable claims data report templates to understand all additional diagnoses and procedures associated with the target population
“Bringing a new treatment to market is an incredibly lengthy and arduous process that requires years of work, hefty investments of time and money, and clearing many regulatory hurdles,” said
Latitude Discovery is part of the Latitude Analytics Suite, a new reporting and analytics package that enables companies of all sizes to accelerate their commercialization efforts with real-time analytics leveraging
Request a demo of Latitude Discovery at definitivehc.com/free-trial.
About
At
Media Contact:
djohns@definitivehc.com
Highwire PR
definitivehealthcare@highwirepr.com
Investor Relations Contact:
ICR for
brian.denyeau@icrinc.com
646-277-1251
Source:
2022 GlobeNewswire, Inc., source